M. Semonský

发表

Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[β-isopropylaminoethyl] ergoline-I

P. Krejčí, K. Řežábek, O. Marhan, 1976, Experientia.

The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats

P. Krejčí, K. Řežábek, M. Auskova, 1973, Experientia.

Substances with antineoplastic activity. XXVII. Some α-subtitution derivatives of δ-(6-purinylthio)valeric and ε-(6-purinylthio)capronic acids

J. Vachek, V. Jelinek, M. Semonský, 1968 .

Carcinostatic agents—XVI. Inhibition of purine biosynthesis and of tetrahydrofolic acid fomylase by β-4-methoxybenzoyl-β-bromoacrylic acid

J. Volejnikova, K. Slavik, V. Slavíková, 1966 .

Ergot alkaloids. XL. Some N-(D-6-methyl-8-isoergolin-I-yl)- and N-(D-6-methyl-8-isoergolin-II-yl)-N'-substituted ureas

K. Řežábek, M. Auskova, M. Semonský, 1972 .

Suppression of Conception with D-6-Methyl-8-cyanomethylergoline(I) in Rats

K. Řežábek, M. Semonský, N. Kucharczyk, 1969, Nature.

Ergot alkaloids. XXX. Synthesis of D-6-methyl-8-ergolin-I-ylacetic acid and some of its derivatives

M. Semonský, N. Kucharczyk, 1968 .

Stimulation of gonadotrophin secretion with the pregnancy inhibitor D-6-methyl-8-cyanomethylergoline (I).

K. Řežábek, O. Marhan, M. Semonský, 1971, Journal of Reproduction and Fertility.

Ergot alkaloids. XXXVIII. Some amides of D-6-methyl-8-ergolin(I)ylacetic acid

M. Beran, K. Řežábek, M. Semonský, 1971 .

Ergot alkaloids. XXXIII. Epimerization of the simpler amides of D-lysergic, D-isolysergic and 1-methyl-D-lysergic acids

M. Semonský, A. Černý, 1969 .

Ergot alkaloids. XXXV. Synthesis of D-6-methyl-8-β-hydroxyethylergolene

M. Beran, K. Řežábek, M. Semonský, 1969 .

Isolation of N-[N-(D-lysergyl)-L-valyl]-cyclo(L-phenylalanyl-D-prolyl) from the ergotoxine type of field ergot and some of its reactions

M. Beran, J. Spáčil, M. Semonský, 1976 .

Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography.

M. Semonský, A. Černý, M. Šaršúnová, 1970, Journal of chromatography.

Substances with antineoplastic activity. XXXIX. γ-Alkoxynaphthyl-α,β-dihalogeno-Δ α,β -crotonolactones; Solvolysis of some of them

V. Jelinek, M. Semonský, B. Kakáč, 1970 .

Some 6-alkyl derivatives of D-8-cyanomethyl and D-8-methyl ergoline-I

M. Semonský, R. Kotva, J. Křepelka, 1977 .

Some 6-substituted derivatives of D-8-cyanomethylergoline-I and D-8-methylergoline-I

M. Semonský, J. Křepelka, A. Černý, 1979 .

Esters of D-6-methyl-8-ergolin-I-ylacetic acid and their 2-halogeno derivatives

M. Beran, K. Řežábek, M. Semonský, 1977 .

Contribution to elucidation of biochemical action mechanism of Cytembena.

K. Slavik, A. Bloch, V. Slavíková, 1971, Neoplasma.

Substances with antineoplastic activity. XXV. Some γ-alkal-α,β-dichloro(dibromo)-Δ α,β -crotonolactones; Products of condensation of γ-methyl-α,β-dibromo-Δ α,β -crotonolactone with some primary amines

M. Semonský, R. Kotva, B. Kakáč, 1968 .

Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.

K. Řežábek, M. Auskova, M. Semonský, 1974, Physiologia Bohemoslovaca.

Cancerostatic Agents XXI. Morphological Changes of the Rat Yoshida Ascites Cells after the Administration of MBBA. The Effect of MBBA on the Amount of Nucleic Acids in these Tumour Cells

V. Jelinek, M. Semonský, H. Veselá, 1967 .

Cancerostat1c agents—XXXVII: The effect of β-aroyl-β-halogen acrylic acids on the tetrahydrofolic acid formylase☆

J. Volejnikova, K. Slavik, V. Slavíková, 1969 .

Reaction of β-4-alkoxybenzoyl-β(α)-bromoacrylic acids and of their esters with sodium methylate and ethylate

J. Holubek, K. Řežábek, M. Semonský, 1977 .